NDC 51144-003

TIVDAK

Tisotumab Vedotin

TIVDAK is a Intravenous Injection, Powder, For Solution in the Human Prescription Drug category. It is labeled and distributed by Seagen Inc.. The primary component is Tisotumab Vedotin.

• Product ID: 51144-003_0c677307-7c46-4bb4-a568-4435271c38ab
• NDC: 51144-003
• Product Type: Human Prescription Drug
• Proprietary Name: TIVDAK
• Generic Name: Tisotumab Vedotin
• Dosage Form: Injection, Powder, For Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2021-09-20
• Marketing Category: BLA /
• Application Number: BLA761208
• Labeler Name: Seagen Inc.
• Substance Name: TISOTUMAB VEDOTIN
• Active Ingredient Strength: 1 mg/mg
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 51144-003-01

1 VIAL in 1 CARTON (51144-003-01) > 40 mg in 1 VIAL

• Marketing Start Date: 2021-09-20
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details